Results 11 to 20 of about 56,178 (231)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection [PDF]

open access: yesNeuropsychiatric Disease and Treatment, 2014
Haya Ascher-Svanum,1 Diego Novick,2,3 Josep Maria Haro,4 Jordan Bertsch,4 David McDonnell,1 Holland Detke11Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly and Company, Windlesham, Surrey, UK; 3Departament de Psiquiatria, Universitat Autonoma de ...
Ascher-Svanum H   +5 more
doaj   +4 more sources

Olanzapine-induced neutropenia [PDF]

open access: yesMental Illness, 2015
Olanzapine-induced neutropenia is a rare adverse effect that is currently poorly described in literature. Although neutropenia is a known adverse effect of clozapine, it has been associated with the use of other antipsychotic medications like olanzapine. This case report describes and reviews a case of olanza-pine-induced neutropenia in a schizophrenic
Kirti Malhotra   +4 more
openaire   +3 more sources

Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data

open access: yesBMC Psychiatry, 2012
Background To treat acute schizophrenia, a long-acting injectable antipsychotic needs a rapid onset of action and therapeutic profile similar to that of oral agents.
Detke Holland C   +2 more
doaj   +1 more source

Olanzapine-induced hiccups: a case report

open access: yesSichuan jingshen weisheng, 2021
The case report aims to raise the concern of clinicians about hiccups as an adverse reaction in olanzapine treatment. A 47-year-old male patient with epileptic mental disorder appeared symptoms of persistent hiccups on the fourth day of treatment with ...
Sun Zhenxiao, Xu Chunmei, Zhao Lin
doaj   +1 more source

Olanzapine induced tardive dyskinesia

open access: yesMedical Journal of Dr. D.Y. Patil University, 2014
Olanzapine is considered to have significantly less risk of tardive dyskinesia (TD) compared to first generation antipsychotics. We describe two patients who developed TD after prolonged use of olanzapine.
Rudraprosad Chakraborty   +2 more
doaj   +1 more source

Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes

open access: yeseLife, 2020
Second-generation antipsychotics are widely used to medicate patients with schizophrenia, but may cause metabolic side effects such as diabetes, which has been considered to result from obesity-associated insulin resistance.
Satoshi Ninagawa   +15 more
doaj   +1 more source

Cannabis and schizophrenia [PDF]

open access: yes, 2014
BACKGROUND Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear
Gillies, Donna   +6 more
core   +1 more source

Olanzapine pamoate use for schizophrenia: Retrospective records based study from a tertiary care hospital

open access: yesIndian Journal of Psychological Medicine, 2020
Background: Little is known from India about the experience of using olanzapine long-acting antipsychotic injectables (LAI). In this background, this study aimed to evaluate the clinical profile of patients suffering from schizophrenia who were ...
Sandeep Grover   +3 more
doaj   +1 more source

The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients [PDF]

open access: yes, 2008
We investigated the relationships between functional genetic variants of the 5-HT(2C) receptor and multidrug-resistant protein (MDR1), coding for P-glycoprotein, and second generation antipsychotic (SDA)-induced weight gain among 108 female schizophrenic
Bilušić, Hrvoje   +5 more
core   +1 more source

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. [PDF]

open access: yes, 2017
ObjectiveParkinson's disease psychosis (PDP) is a frequent complication of idiopathic Parkinson's disease (iPD) with significant impact on quality of life and association with poorer outcomes.
Bizzarri   +29 more
core   +2 more sources

Home - About - Disclaimer - Privacy